Answer
Taking sotorasib with rifampicin is not recommended because this strong CYP3A4 inducer decreases sotorasib exposure (Cmax by 35% and AUC by 51% with multiple inducer doses), and the impact on sotorasib efficacy is unknown.
Sources for this answer
- LUMYKRAS 240 mg film-coated tabletsAmgen Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked